Home » Cancer Articles » Ana Tari, Ph.D., MBA, Recognized by Cambridge Who's Who for Excellence in Biochemistry
Ana Tari, Ph.D., MBA, Recognized by Cambridge Who's Who for Excellence in Biochemistry
Dr. Tari's research has led to the development of six patents
GAINESVILLE, FL, October 03, 2011 /Cancer PR News/ -- Ana Tari, Director of Preclinical Operations and Research at Bio-Path Holdings, Inc., has been recognized by Cambridge Who's Who for showing dedication, leadership and excellence in biochemistry.
As the director of preclinical operations and research at Bio-Path Holdings, Inc., Dr. Tari is responsible for the Company's evaluation and selection of new drug targets for licensing and development; design, source and direct preclinical studies; and be the primary scientific liaison to the scientific community and clinical trial sites. Dr. Tari's research in liposome delivery of nucleic acids has resulted in the issuance of numerous U.S. and international patents that are licensed to Bio-Path Holdings, Inc. She was the lead researcher who developed the Company's lead drug candidate that is currently in a Phase I clinical trial in blood cancers. Dr. Tari attributes her success to a lot of hard work, determination, and the support she receives from her family. She became involved in her profession because of her goal of eventually reducing cancer mortality rates.
Dr. Tari earned a Ph.D. in biochemistry from the University of Tennessee, Knoxville in 1992 and an MBA from the University of Florida, Gainesville in 2011. She is a member of the American Association for Cancer Research and Beta Gamma Sigma, Inc. In addition, she is an associate professor at The University of Florida. Her academic research focuses on developing tumor-targeting technology to enhance the delivery and effectiveness of anti-cancer drugs.
In the near future, Dr. Tari hopes to expand her business relationships and business experiences, and move into a more executive management role in a biotechnology or pharmaceutical company.
For more information about Bio-Path Holdings, Inc., visit http://www.biopathholdings.com.
About Cambridge Who's Who
With over 400,000 members representing every major industry, Cambridge Who's Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Cambridge Who's Who employs similar public relations techniques to those utilized by Fortune 500 companies and makes them cost-effective for members who seek to take advantage of its career enhancement and business advancement services. Cambridge is pleased to welcome its new Executive Director of Global Branding and Networking, Donald Trump Jr., who is eager to share his extensive experience in this arena with members.
Cambridge Who's Who membership provides individuals with a valuable third party endorsement of their accomplishments and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.
For more information, please visit http://www.cambridgeregistry.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website |
|
|
|
|
|
|
Advertise With Us |
About Us |
Contact Us